Oregon BioEvolution Poster: Now available...
We extend a special thank you to the many companies and organizations that are helping to promote
Oregon's biotechnology, medical device and healthcare industry, including Amgen, Economic Development
For Central Oregon, Davis Wright Tremaine, Fred Hutchinson Cancer Research Center, Lease Crutcher Lewis, Merck & Co.,
Oregon Bioscience Association, Oregon Health & Science University, Perkins Coie, Portland Development Commission,
Ratner BioMedical, SAB Architects, Tonkon Torp, ZymoGenetics and others -- sponsors of the
first ever Oregon BioEvolution poster.
Oregon BioEvolution is a one-of-a-kind genealogy chart that illustrates the founding "technology origins" of more
than 100 biotechnology and medical device firms located in the state of Oregon.
 More...
Destination Oregon
Are you considering a move to Oregon? Relocating your business to
Oregon? Starting a company? Or just interested in Oregon?
This section will answer many of your questions regarding the life science industry in Oregon, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Ondine announces FDA confirmation of regulatory pathway for Periowave(TM) Ondine Biopharma announced it has received confirmation from the U.S. Food & Drug Administration (FDA) that the Company's Periowave(TM) Photodisinfection System will be evaluated as a Class III medical device under premarket approval (PMA) regulations.
Ondine Biopharma Corporation August 27, 2008
- Cell Genesys halts VITAL-2 GVAX trial in advanced prostate cancer Cell Genesys announced that it has terminated VITAL-2, the second of two Phase 3 clinical trials of GVAX immunotherapy for prostate cancer, which compares GVAX immunotherapy in combination with Taxotere(R) (docetaxel) to Taxotere plus prednisone in patients with advanced-stage prostate cancer.
Cell Genesys, Inc. August 27, 2008
- Amylin Pharmaceuticals and Eli Lilly provide context for FDA alert for BYETTA Amylin Pharmaceuticals and Eli Lilly and Company in a conference call provided context and additional information regarding the August 18, 2008 U.S. Food and Drug Administration (FDA) update to a prior alert for BYETTA(R) (exenatide) injection referencing pancreatitis.
Amylin Pharmaceuticals, Inc. August 26, 2008
- Bristol-Myers Squibb and Pfizer provide update on apixaban clinical development program Bristol-Myers Squibb Company and Pfizer provided an update on the apixaban clinical development program. The companies announced that new Phase II data in acute coronary syndrome patients (ACS) will be presented at the upcoming meeting of the European Society of Cardiology (ESC).
Pfizer Inc. August 26, 2008
- Gen-Probe announces $250 million stock repurchase plan Gen-Probe announced that its board of directors has authorized the repurchase of up to $250 million of the Company's common stock over the next two years.
Gen-Probe Incorporated August 26, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
Surplus Equipent & Supplies for Sale!
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Oregon's BioHistory
Why is there a biotechnology industry in Oregon? Will the industry continue
to grow in Oregon? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Oregon BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Oregon.
More...
BioEvolution Posters
More...
Pre-teens Need Vaccines Too!
Vaccines are not just for infants. As kids get older, protection provided by
some childhood vaccines can begin to wear off. Kids can also develop risks for
more diseases as they enter their pre-teen years. Help your child transition
into adolescence in a healthy way by staying up-to-date on pre-teen
vaccines.
Doctors recommend that all 11 and 12 year olds get the Tdap and
meningococcal vaccines; 11- and 12-year-old girls should also get the human
papillomavirus (HPV) vaccine.
More...
BioFact
(1942) - President Franklin Roosevelt publicly denounces germ warfare as an inhumane form of warfare. Privately, he approves a top-secret plan for the U.S. to develop biological warfare capability. A year later, the U.S. has a four-pound anthrax bomb.
It's a Small World
|
| |
Cancer Cell
| |
Science Quote
"The secret to creativity is knowing how to hide your sources."
| - |
Albert Einstein
|
|
(1879-1955)
|
|
